|
|
Article: Study findings on life sciences are outlined in reports from Kanazawa University.(Report)
- Article from:
- Cancer Weekly
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
New research, 'Evaluation of radioiodinated vesamicol analogs for sigma receptor imaging in tumor and radionuclide receptor therapy,' is the subject of a report. According to recent research from Kanazawa, Japan, "It has been reported that sigma receptors are highly expressed in a variety of human tumors. In this study, we selected (+)-2-[4-(4-iodophenyl)piperidino] cyclohexanol [(+)-pIV] as a sigma receptor ligand and evaluated the potential of radioiodinated (+)-pIV for tumor imaging and therapy. (+)-[(125/131)I]pIV was prepared by an iododestannylation reaction under no-carrier-added conditions with radiochemical purity over 99% after HPLC purification."
...
Related newspaper, magazine, and journal articles:
|
|
Article: Kanazawa University details research in gastric ...
Cancer Weekly;
September 22, 2009 ;
700+ words
... ... wrote T. Fujimura and colleagues, Kanazawa University (see also Gastric Cancer). The ... information, contact T. Fujimura, Kanazawa University Hospital, 13-1 Takaramachi ... Lymphadenectomy, Oncology, Surgery, Kanazawa University. This article was prepared by Cancer ...
|
|